Neurocrine (NBIX) Ownership - Who Owns Neurocrine?

Compare

1,557 Followers

Neurocrine (NBIX) Ownership Overview

1.17% Insiders

27.47% Mutual Funds

24.83% Other Institutional Investors

27.44% ETFs

19.08% Public Companies and Individual Investors

The ownership structure of Neurocrine (NBIX) stock is a mix of institutional, retail, and individual investors. Approximately 79.75% of the company’s stock is owned by Institutional Investors, 1.17% is owned by Insiders, and 19.08% is owned by Public Companies and Individual Investors.

The ownership structure of Neurocrine (NBIX) stock is a mix of institutional, retail, and individual investors. Approximately 52.30% of the company’s stock is owned by Institutional Investors, 1.17% is owned by Insiders, and 27.44% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2025	Manning & Napier Advisors Llc	xxxxxxxxxxxxx	$3120
Dec 31, 2025	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$259407
Dec 31, 2025	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$690570
Dec 31, 2025	Suncoast Equity Management	xxxxxxxxxxxxx	$721205

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	11,215,152	Institution	11.17%	1,456,287,487
	8,452,490	Institution	8.42%	1,097,555,827
	7,742,780	Institution	7.71%	1,005,399,983
John A. Gunn	5,508,042	Institution	5.49%	715,219,254
	4,428,563	Institution	4.41%	575,048,906
	2,444,682	Institution	2.44%	317,441,958
	1,220,482	Institution	1.22%	158,479,588
James E. Flynn	1,184,345	Institution	1.18%	153,787,198
	1,179,084	Institution	1.17%	153,104,057
	1,103,444	Institution	1.10%	143,282,203

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
7,742,780	Institution	7.71%	1,005,399,983
4,428,563	Institution	4.41%	575,048,906
1,220,482	Institution	1.22%	158,479,588
1,179,084	Institution	1.17%	153,104,057
978,885	Institution	0.98%	127,108,217
959,773	Institution	0.96%	124,626,524
612,474	Institution	0.61%	79,529,749
597,566	Institution	0.60%	77,593,945
483,344	Institution	0.48%	62,762,218
473,847	Institution	0.47%	61,529,033

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Core S&P Mid-Cap ETF	3,227,984	Institution	3.22%	419,153,722
Vanguard Total Stock Market ETF	3,135,833	Institution	3.12%	426,661,438
iShares S&P Mid-Cap ETF CDI	3,000,296	Institution	2.99%	285,478,164
Vanguard Small-Cap ETF	2,258,552	Institution	2.25%	307,298,585
Vanguard Small-Cap Growth ETF	1,254,757	Institution	1.25%	170,722,237
Vanguard Extended Market ETF	1,076,567	Institution	1.07%	146,477,706
SPDR S&P Midcap 400 ETF Trust	736,132	Institution	0.73%	95,586,740
iShares Biotechnology ETF	704,078	Institution	0.70%	91,375,243
First Trust NYSE Arca Biotechnology Index Fund	599,181	Institution	0.60%	77,803,653
SPDR S&P BIOTECH ETF	598,433	Institution	0.60%	77,664,635

FAQ

Who Owns Neurocrine (NBIX)?

According to the latest TipRanks data, approximately 24.83% of the company's stock is held by institutional investors, 1.17% is held by insiders, and 19.08% is held by retail investors.

What percentage of Neurocrine (NBIX) stock is held by institutional investors?

According to the latest TipRanks data, approximately 24.83% of Neurocrine (NBIX) stock is held by institutional investors.

What percentage of Neurocrine (NBIX) stock is held by retail investors?

According to the latest TipRanks data, approximately 19.08% of Neurocrine (NBIX) stock is held by retail investors.

Who owns the most shares of Neurocrine (NBIX)?

iShares owns the most shares of Neurocrine (NBIX).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.